touchPODCAST

touchPODCAST

By touchpodcastScience
Download on the App Store

touchPODCAST episodes

  • Improving outcomes for patients with NTM-LD

    touchEXPERT OPINIONS for touchRESPIRATORY

    Listen to leading experts consider how to optimize the diagnosis of nontuberculous mycobacterial lung disease (NTM-LD) and how to manage it considering the latest treatment guidelines.

    The experts

    • Dr Juzar Ali, LSU Health Sciences Center, New Orleans, LA, USA
  • Dr Doreen Addrizzo-Harris, NYU Grossman School of Medicine, New York, NY, USA
  • Dr Kevin Winthrop, Oregon Health & Science University, Portland, OR, USA

    • This touchPODCAST is for HCPs only.

    This activity is funded by an unrestricted independent medical education grant from Insmed. This activity is jointly provided by USF Health and touchIME. 

    For further information visit our website: https://touchrespiratoryime.org/guideline-based-strategies-ntm-ld

    38 min
  • Achieving sustained outcomes for moderate-to-severe atopic dermatitis

    touchTALKS for touchIMMUNOLOGY

    This touchPODCAST is presented by Dr Melinda Gooderham, SKiN Centre for Dermatology, Peterborough, Ontario, Canada.

    Listen to Dr Gooderham present the latest data and future directions of systemic therapy for moderate-to-severe atopic dermatitis and how effective treatment can achieve sustained control of symptoms and improve the quality of life of patients and their families.

    This touchPODCAST is for HCPs only.

    This activity is funded by an unrestricted independent educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.

    For further information visit our website:  https://touchimmunologyime.org/systemic-therapy-atopic-dermatitis

    39 min
  • Perspectives on the latest clinical data for targeted therapies for thyroid cancer

    touchMDT for touchONCOLOLOGY

    Listen to key experts from a multidisciplinary team discuss the latest efficacy and safety data for targeted therapies for thyroid cancer 

     The multidisciplinary team 

    • Endocrinologist: Dr Antonio Matrone, Italy
  • Nurse specialist: Ms Tara Hurley, UK
  • Oncologist: Dr Lori Wirth, USA

    • This touchPODCAST is for HCPs only.

    This activity is funded by an unrestricted independent medical education grant from Eli Lilly and Bayer. This activity is jointly provided by USF Health and touchIME.

    For further information visit our website: https://touchoncologyime.org/personalized-approach-to-treatment-thyroid-cancer-biomarkers-and-targeted-therapies//

    19 min
  • Perspectives on biomarker testing and its influence on outcomes in patients with thyroid cancer

    touchMDT for touchONCOLOLOGY

    Listen to key experts from a multidisciplinary team explore the use of biomarkers in thyroid cancer care and how personalized medicine influences patient outcomes

    The multidisciplinary team 

    • Pathologist: Dr Peter Sadow, USA
  • Endocrinologist: Dr Antonio Matrone, Italy
  • Oncologist: Dr Lori Wirth, USA

    • This touchPODCAST is for HCPs only.

    This activity is funded by an unrestricted independent medical education grant from Eli Lilly and Bayer. This activity is jointly provided by USF Health and touchIME.

    For further information visit our website: https://touchoncologyime.org/personalized-approach-to-treatment-thyroid-cancer-biomarkers-and-targeted-therapies//

    18 min
  • An overview of thyroid cancers from a MDT of experts

    touchMDT for touchONCOLOGY

    Listen to key experts from a multidisciplinary team (MDT) discuss the epidemiology of thyroid cancer, available treatment options, and the role of the MDT in patient care

    The multidisciplinary team

    • Oncologist: Dr Lori Wirth, USA
  • Endocrinologist: Dr Antonio Matrone, Italy
  • Nurse specialist: Ms Tara Hurley, UK
  • Pathologist: Dr Peter Sadow, USA

    • This touchPODCAST is for HCPs only.

    This activity is funded by an unrestricted independent medical education grant from Eli Lilly and Bayer. This medical education is jointly provided by USF Health and touchIME.

    For further information visit our website: https://touchoncologyime.org/personalized-approach-to-treatment-thyroid-cancer-biomarkers-and-targeted-therapies//

    17 min
  • Expert opinions on the management of EDS due to OSA or narcolepsy

    touchEXPERT OPINIONS for touchNEUROLOGY

    Listen to leading sleep medicine experts discuss strategies for the optimal management of excessive daytime sleepiness (EDS) associated with obstructive sleep apnea (OSA) or narcolepsy, and share insights and potential implications for clinical practice.

    The experts

    • Dr Annamaria Iakovou – Northwell Health, Lake Success, New York, NY, USA
  • Prof. Helene A Emsellem – Center of Sleep & Wake Disorders, Chevy Chase, MD, USA
  • Prof. Gert Jan Lammers – Sleep-Wake Centres SEIN, Leiden University Medical Centre, Leiden, Netherlands

    • This touchPODCAST is for HCPs only.

    This activity is funded by an unrestricted independent educational grant from Jazz Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.

    For further information visit our website:

    https://touchneurologyime.org/managing-eds-in-osa-or-narcolepsy

    31 min
  • Expert opinions on the management of EDS due to OSA or narcolepsy

    touchEXPERT OPINIONS for touchRESPIRATORY

    Listen to leading sleep medicine experts discuss strategies for the optimal management of excessive daytime sleepiness (EDS) associated with obstructive sleep apnea (OSA) or narcolepsy, and share insights and potential implications for clinical practice.

    The experts

    • Dr Annamaria Iakovou – Northwell Health, Lake Success, New York, NY, USA
  • Prof. Helene A Emsellem – Center of Sleep & Wake Disorders, Chevy Chase, MD, USA
  • Prof. Gert Jan Lammers – Sleep-Wake Centres SEIN, Leiden University Medical Centre, Leiden, Netherlands

    • This touchPODCAST is for HCPs only.

    This activity is funded by an unrestricted independent educational grant from Jazz Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.

    For further information visit our website:  https://touchrespiratoryime.org/managing-eds-in-osa-or-narcolepsy

    31 min
  • Evolving Standards Of Patient Care in Hepatocellular carcinoma 3

    touchMDT for touchONCOLOGY

    Listen to a multidisciplinary tumour board consider the potential of systemic therapy in hepatocellular carcinoma during the current immunotherapy era.

    The multidisciplinary team

    • Medical oncologist: Prof. Ahmed Kaseb, USA
  • Radiation oncologist: Prof. Jinsil Seong, Korea
  • Hepatologist: Prof. Peter Galle, Germany
  • Surgical oncologist: Dr Michael Choti, USA

    • This touchPODCAST is for HCPs only. 


    This activity is funded by an unrestricted independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME. 

    For further information visit our website: https://touchoncologyime.org/patient-care-in-HCC/

    12 min
  • Evolving Standards Of Patient Care in Hepatocellular carcinoma 2

    touchMDT for touchONCOLOGY

    Listen to a multidisciplinary tumour board discuss how recent developments are enabling the management of patients with hepatocellular carcinoma to become increasingly individualized.

    The multidisciplinary team

    • Medical oncologist: Prof. Ahmed Kaseb, USA
  • Radiation oncologist: Prof. Jinsil Seong, Korea
  • Hepatologist: Prof. Peter Galle, Germany
  • Surgical oncologist: Dr Michael Choti, USA

    • This touchPODCAST is for HCPs only. 


    This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME. 

    For further information visit our website: https://touchoncologyime.org/patient-care-in-HCC/

    12 min
  • Evolving Standards Of Patient Care in Hepatocellular carcinoma

    touchMDT for touchONCOLOGY

    Listen to a multidisciplinary tumour board share their perspectives on a best practice multidisciplinary approach to patient care in the management of hepatocellular carcinoma.

    The multidisciplinary team

    • Medical oncologist: Prof. Ahmed Kaseb, USA
  • Radiation oncologist: Prof. Jinsil Seong, Korea
  • Hepatologist: Prof. Peter Galle, Germany
  • Surgical oncologist: Dr Michael Choti, USA

    • This touchPODCAST is for HCPs only. 


    This activity is funded by an unrestricted independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME. 

    For further information visit our website: https://touchoncologyime.org/patient-care-in-HCC/

    12 min

About touchPODCAST

From the publisher's feed

Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites.